These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 12444892

  • 21. Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience.
    Mul D, Oostdijk W, Otten BJ, Rouwé C, Jansen M, Delemarre-van de Waal HA, Waelkens JJ, Drop SL.
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():765-72. PubMed ID: 10969919
    [Abstract] [Full Text] [Related]

  • 22. [Comparison between complete and incomplete suppression of the hypophyseal-gonadal axis in girls with central precocious puberty: effect on growth and prospective final height].
    Partsch CJ, Hümmelink R, Sippell WG, Oostdijk W, Odink RJ, Drop SL.
    Monatsschr Kinderheilkd; 1993 Dec; 141(12):935-9. PubMed ID: 8114776
    [Abstract] [Full Text] [Related]

  • 23. Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty.
    Lee HS, Yoon JS, Park KJ, Hwang JS.
    PLoS One; 2018 Dec; 13(8):e0201906. PubMed ID: 30133462
    [Abstract] [Full Text] [Related]

  • 24. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L, Sólyom E, Lombay B, Almási A, Vámosi I.
    Orv Hetil; 2012 Mar 18; 153(11):418-24. PubMed ID: 22390866
    [Abstract] [Full Text] [Related]

  • 25. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method.
    Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z.
    Horm Res; 1997 Mar 18; 47(2):54-61. PubMed ID: 9030968
    [Abstract] [Full Text] [Related]

  • 26. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
    Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G.
    Eur J Pediatr; 1998 May 18; 157(5):363-7. PubMed ID: 9625331
    [Abstract] [Full Text] [Related]

  • 27. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F.
    J Clin Endocrinol Metab; 1999 Feb 18; 84(2):449-52. PubMed ID: 10022399
    [Abstract] [Full Text] [Related]

  • 28. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
    Brito VN, Latronico AC, Cukier P, Teles MG, Silveira LF, Arnhold IJ, Mendonca BB.
    J Clin Endocrinol Metab; 2008 Jul 18; 93(7):2662-9. PubMed ID: 18460564
    [Abstract] [Full Text] [Related]

  • 29. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment.
    Tatò L, Saggese G, Cavallo L, Antoniazzi F, Corrias A, Pasquino AM, Cisternino M.
    Horm Res; 1995 Jul 18; 44 Suppl 3():49-54. PubMed ID: 8719441
    [Abstract] [Full Text] [Related]

  • 30. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J, Reynaud R, Czernichow P.
    J Pediatr; 2000 Dec 18; 137(6):819-25. PubMed ID: 11113839
    [Abstract] [Full Text] [Related]

  • 31. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist.
    Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwé C, Jansen M, Gerver WJ, Waelkens J, Drop S.
    Arch Dis Child; 1996 Oct 18; 75(4):292-7. PubMed ID: 8984913
    [Abstract] [Full Text] [Related]

  • 32. When to stop GnRH analog therapy: the experience of the Italian Study Group for Physiopathology of Puberty.
    Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F, Borrelli P, Crisafulli G, Wasniewska M, De Luca F.
    J Pediatr Endocrinol Metab; 2000 Jul 18; 13 Suppl 1():759-64. PubMed ID: 10969918
    [Abstract] [Full Text] [Related]

  • 33. End results in central precocious puberty with GnRH analog treatment: the data of the Italian Study Group for Physiopathology of Puberty.
    Antoniazzi F, Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Borrelli P, Osio D, Mengarda F, De Luca F, Tatò L.
    J Pediatr Endocrinol Metab; 2000 Jul 18; 13 Suppl 1():773-80. PubMed ID: 10969920
    [Abstract] [Full Text] [Related]

  • 34. [Improvement of expected and final height in girls with central precocious puberty treated with gonadotropin releasing hormone analogues].
    Gómez F, Picó AM, Vargas F, Mauri M.
    Med Clin (Barc); 1996 Nov 23; 107(18):681-4. PubMed ID: 9082075
    [Abstract] [Full Text] [Related]

  • 35. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height.
    Lazar L, Kauli R, Pertzelan A, Phillip M.
    J Clin Endocrinol Metab; 2002 May 23; 87(5):2090-4. PubMed ID: 11994346
    [Abstract] [Full Text] [Related]

  • 36. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb 23; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

  • 37. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
    Pasquino AM, Pucarelli I, Accardo F, Demiraj V, Segni M, Di Nardo R.
    J Clin Endocrinol Metab; 2008 Jan 23; 93(1):190-5. PubMed ID: 17940112
    [Abstract] [Full Text] [Related]

  • 38. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
    Liang Y, Wei H, Zhang JL, Hou L, Luo XP.
    Zhonghua Er Ke Za Zhi; 2004 Nov 23; 42(11):845-9. PubMed ID: 15631714
    [Abstract] [Full Text] [Related]

  • 39. Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty.
    Shim YS, Lim KI, Lee HS, Hwang JS.
    PLoS One; 2020 Nov 23; 15(12):e0243212. PubMed ID: 33301485
    [Abstract] [Full Text] [Related]

  • 40. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function.
    Heger S, Partsch CJ, Sippell WG.
    J Clin Endocrinol Metab; 1999 Dec 23; 84(12):4583-90. PubMed ID: 10599723
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.